#COVID19 clinical trials dashboard sneak peek. 620+ trials from 50+ countries. 290+ RCTs. 90+ drug classes. Viz by Marina Marin. #coronavirus @EricTopol @DrEricDing @VPrasadMDMPH @AbraarKaran @DrTomFrieden @HelenBranswell @NIHdirector /1 
Here's a snapshot of #COVID19 randomized trials.
@DrChoueiri @Laurie_Garrett @alexismadrigal @DrDenaGrayson @ashishkjha @cmyeaton /2
@DrChoueiri @Laurie_Garrett @alexismadrigal @DrDenaGrayson @ashishkjha @cmyeaton /2
Here's a snapshot of #COVID19 trials broken down by top countries: US, China, France, Italy. @V2019N @mlipsitch @neil_ferguson @TDivala @SusanDavisNY @martinoffringa /3
Full listing of #COVID19 trial therapies/mechanisms here. New therapeutic classes being reported daily. @Dereklowe @DavidJuurlink @DrJudyStone @FranciscoMarty_ @angie_rasmussen /4
Some therapies target specific phases of #SARSCoV2 viral life cycle, as beautifully depicted in these @JAMA_current, @JACCJournals, and @NEJM figures. /5
Many therapies aim to modulate immune response in ways nonspecific to #SARSCoV2. Robust experimental pipeline as well. nature.com/articles/d4158… @nature @NatureBiotech /6
Dashboard methods, glossary, disclaimer here. Plan to update at least weekly. Public release soon. #MedTwitter what do you think? @vasudevbailey /7
